Low Specific Gravity of Urine: Causes, What It Means, and When to Act

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Urine specific gravity measures the concentration of dissolved solutes relative to pure water, reflecting how well the kidneys concentrate or dilute urine in response to hydration and ADH signalling. A low result (below ~1.005) most commonly reflects high fluid intake before collection—a normal physiological response—though persistently dilute urine may reflect diabetes insipidus or early chronic kidney disease (isosthenuria ~1.010). Interpreting specific gravity alongside hydration status, symptoms, and serum creatinine distinguishes benign over-hydration from conditions requiring further investigation.

Read more →

Understand what your kidney function testing results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Quick answer: Urine specific gravity measures how concentrated your urine is. A low result (typically below 1.005) indicates that the kidneys are producing very dilute urine. The most common cause is high fluid intake, but persistent low specific gravity can also reflect kidney concentrating impairment, diabetes insipidus, or early kidney dysfunction. Context and concurrent markers determine clinical significance.

What a low urine specific gravity tells you

Specific gravity is a measure of urine density relative to pure water, reflecting the concentration of dissolved substances — primarily electrolytes, urea, and creatinine — in the urine. Healthy kidneys can concentrate urine over a wide range depending on hydration status and the body's need to retain or excrete water. This concentrating ability is one of the kidney's most fundamental functions: it allows the body to maintain water and electrolyte balance across variable fluid intake and environmental conditions.

The reference range for urine specific gravity is generally 1.005 to 1.030. Values below 1.005 indicate urine that is more dilute than normal. Values above 1.030 indicate very concentrated urine. A single reading outside this range is often without clinical significance on its own; the pattern over time and the clinical context determine whether further investigation is warranted.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Causes of low urine specific gravity

High fluid intake

The most common explanation for low specific gravity is simply drinking a large volume of fluid before or during urine collection. When water intake exceeds the body's needs, the kidneys respond by producing larger volumes of dilute urine to maintain fluid balance. This is a normal physiological response and produces specific gravity readings that may fall below 1.005. In this context, a low result is not clinically significant — it reflects appropriate kidney function, not impairment.

This is why urine specific gravity must be interpreted alongside the collection context. A low result from a sample collected after consuming a large volume of water before the test is fundamentally different from a low result on a first-morning urine sample collected before any fluid intake, when the kidneys would normally be producing more concentrated urine.

Diabetes insipidus

Diabetes insipidus (DI) is a condition in which the kidneys produce abnormally large volumes of dilute urine regardless of hydration status. It is distinct from diabetes mellitus and involves a defect either in the production of antidiuretic hormone (ADH) by the pituitary (central DI) or in the kidney's response to ADH (nephrogenic DI). ADH normally signals the collecting ducts of the kidney to reabsorb water and concentrate the urine; when this signal is absent or ignored, the result is persistent dilute urine with specific gravity consistently below 1.005 even in the context of dehydration.

Symptoms of diabetes insipidus include dramatic increases in urinary frequency and volume (polyuria), intense thirst, and nocturia. The condition is relatively rare but clinically important because it produces significant dehydration risk if fluid intake cannot keep pace with losses. Diagnosis typically involves water deprivation testing and measurement of plasma and urine osmolality rather than specific gravity alone.

Chronic kidney disease and concentrating impairment

Healthy kidneys can adjust specific gravity over a wide range in response to hydration changes. As kidney function declines in chronic kidney disease, this concentrating and diluting capacity is progressively lost — a condition called isosthenuria, where urine specific gravity remains fixed near 1.010 regardless of hydration status. This fixed, low-normal specific gravity in the context of high fluid intake is an early indicator of reduced tubular function, distinct from the very low values seen in diabetes insipidus.

Kidney function should be assessed through serum markers when CKD is suspected. Relevant tests include eGFR (estimated glomerular filtration rate), serum creatinine, and blood urea nitrogen (BUN). Electrolytes including sodium and potassium provide additional context for tubular function. Reference ranges vary by laboratory and individual; results should be interpreted by a qualified provider.

Diuretic use

Diuretic medications (loop diuretics such as furosemide, thiazides, and potassium-sparing diuretics) work by inhibiting sodium and water reabsorption in specific segments of the renal tubule, increasing urine output and reducing fluid volume. Urine produced during diuretic therapy is typically dilute, with low specific gravity. A low specific gravity in a patient taking diuretic medication is expected and does not indicate a separate pathology — it is the intended mechanism of action of the medication.

Early or mild adrenal insufficiency

Cortisol and aldosterone, produced by the adrenal glands, play roles in sodium retention and fluid balance. Deficiency of these hormones in adrenal insufficiency can impair the kidney's ability to retain sodium and water, producing dilute urine. This is not a common cause of isolated low urine specific gravity but is relevant in the clinical context of symptoms including unexplained fatigue, low blood pressure, and weight loss.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

Which biomarkers to assess alongside low specific gravity

  • eGFR — kidney filtration rate; detects reduced kidney function
  • Serum creatinine — Waste product from muscle metabolism; rises when kidney filtration declines
  • BUN (Blood urea nitrogen) — Nitrogen waste product that reflects kidney clearance and protein metabolism, included in metabolic panels
  • Sodium — primary extracellular electrolyte; low sodium (hyponatremia) can occur with excess water intake
  • Potassium — Intracellular electrolyte; affected by kidney function and diuretic use
  • Fasting glucose — elevated glucose causes osmotic diuresis and dilute urine via a separate mechanism
  • HbA1c — average blood sugar over 3 months; detects diabetes-related causes of polyuria

Superpower's Baseline Blood Panel includes eGFR, creatinine, BUN, sodium, potassium, fasting glucose, and HbA1c — covering the primary serum markers relevant to interpreting urinary concentrating function and identifying systemic contributors to dilute urine.

When to take this seriously

A single low specific gravity reading in the context of high fluid intake before sample collection is typically not clinically significant. Persistent low specific gravity — particularly on first-morning samples collected before significant fluid intake — is more meaningful. This warrants evaluation for kidney concentrating impairment, diabetes insipidus, or undetected diabetes mellitus (where osmotic diuresis from glycosuria produces dilute, frequent urine).

If low specific gravity is accompanied by symptoms of increased urination, intense thirst, nocturia (frequent urination at night), or unexplained fatigue, bring this pattern to a clinician's attention. These symptoms together, rather than a single urine value in isolation, provide the clinical picture that guides next steps.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider regarding any urinary or kidney concerns. Superpower offers blood panels that include the biomarkers discussed in this article. Links to individual tests are provided for informational context.

Frequently Asked Questions

References

  1. Pradella M, Dorizzi RM, Rigolin F (1988). Relative density of urine: methods and clinical significance. *Critical reviews in clinical laboratory sciences*, *26*(3), 195-242. https://doi.org/10.3109/10408368809105890
  2. Mutter CM, Smith T, Menze O, Zakharia M, Nguyen H (2021). Diabetes Insipidus: Pathogenesis, Diagnosis, and Clinical Management. *Cureus*, *13*(2), e13523. https://doi.org/10.7759/cureus.13523
  3. Makaryus AN, McFarlane SI (2006). Diabetes insipidus: diagnosis and treatment of a complex disease. *Cleveland Clinic journal of medicine*, *73*(1), 65-71. https://doi.org/10.3949/ccjm.73.1.65
  4. Kovesdy CP (2012). Significance of hypo- and hypernatremia in chronic kidney disease. *Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association*, *27*(3), 891-8. https://doi.org/10.1093/ndt/gfs038
  5. Quintanilla AP (1981). Pathophysiology of renal concentrating defects. *Annals of clinical and laboratory science*, *11*(4), 300-7. https://pubmed.ncbi.nlm.nih.gov/6791572/
  6. Imhof PR, Hushak J, Schumann G, Dukor P, Wagner J, Keller HM (1972). Excretion of urinary casts after the administration of diuretics. *British medical journal*, *2*(5807), 199-202. https://doi.org/10.1136/bmj.2.5807.199
  7. Spital A (1982). Hyponatremia in adrenal insufficiency: review of pathogenetic mechanisms. *Southern medical journal*, *75*(5), 581-5. https://doi.org/10.1097/00007611-198205000-00018

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey